Product Categories
| Country: | China |
|---|---|
| Tel: | 13720134139 086-15871494362 |
| Mobile: | 13720134139 |
| E-mail: | |
| QQ: | |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Z-VAD-FMK | C22H30FN3O7 | 187389-52-2 | Details |
| 1H,4H,5H-Benzo[g]indazole | C11H10N2 | 24445-06-5 | Details |
| 2,7-Di-tert-butyl-9,9-diMethylxanthene | C23H30O | 130525-41-6 | Details |
| di(pyridin-3-yl)amine | C10H9N3 | 1915-41-9 | Details |
| 4'-AMINO-2,2':6',2''-TERPYRIDINE | C15H12N4 | 193944-66-0 | Details |
| Glenzocimab | 2101829-58-5 | Details |
| Research Grade Relfovetmab | 2171034-70-9 | Details |
| Disitamab | 2185868-98-6 | Details |
| N-Phenyl-N'-(2-methylphenyl)-p-phenylenediamine | C19H18N2 | 27173-16-6 | Details |
| Momelotinib | C23H22N6O2 | 1056634-68-4 | Details |
| Ethyl 6-mercaptopyridazine-3-carboxylate | C7H8N2O2S | 176658-62-1 | Details |
| 3,3'-Bithiophene | C8H6S2 | 3172-56-3 | Details |
| Teclistamab | 2119595-80-9 | Details |
| Nimacimab | 2098636-09-8 | Details |
| Nidanilimab | 2171061-85-9 | Details |
| Cosibelimab | 2216751-26-5 | Details |
| 4-Hydrazinobenzoic Acid-d4 Hydrochloride | C7H5D4ClN2O2 | 1246816-67-0 | Details |
| 3,6-Di(pyridin-4-yl)-9H-carbazole | C22H15N3 | 1446275-54-2 | Details |
| Naxitamab | 1879925-92-4 | Details |
| Balstilimab | 2230167-06-1 | Details |
| Plamotamab | 2138442-31-4 | Details |
| 2-(4-(Pyridin-4-yl)phenyl)acetonitrile | C13H10N2 | 112170-33-9 | Details |
| 2,2';6',2'']Terpyridine-6,6''-dicarboxylic acid | C17H11N3O4 | 149982-11-6 | Details |
| 3,6-Dibromo-9-ethyl-9H-carbazole | C14H11Br2N | 33255-13-9 | Details |
| triphenylene-1,5,9-triamine | C18H15N3 | 371786-11-7 | Details |
| Vofatamab | 1312305-12-6 | Details |
| Zalifrelimab | 2148321-69-9 | Details |
| Vibecotamab | 2138442-13-2 | Details |
| Astegolimab | 2173054-79-8 | Details |
| 4-Chloro-6-(methoxymethyl)-2-(pyridin-3-yl)pyrimidine | C11H10ClN3O | 339279-00-4 | Details |
| 1H-1,2,4-TRIAZOLE,3,5-BIS(TRIFLUOROMETHYL)- | C4HF6N3 | 709-62-6 | Details |
| Benzaldehyde, 4,4',4''-phosphinidynetris- | C21H15O3P | 67753-41-7 | Details |
| 1,4-Benzenedicarboxylic acid, 2,3-difluoro- | C8H4F2O4 | 1220509-29-4 | Details |
| 2,5-Cyclohexadiene-1,4-dione, 2-[(1,3-dimethylbutyl)amino]-5-(phenylamino)- | C18H22N2O2 | 2754428-18-5 | Details |
| Research Grade Avizakimab | 2229685-51-0 | Details |
| Amikacin | C22H43N5O13 | 37517-28-5 | Details |
| racFTY720 Phosphate | C19H34NO5P | 402615-91-2 | Details |
| 1,3-BIS(2-HYDROXY-4-DIETHYLAMINO-PHENYL)-2-OXO-CYCLOBUTENYLIUM-4-OLAT | C24H28N2O4 | 68842-66-0 | Details |
| Volagidemab | 1233956-13-2 | Details |
| Benzamidoxime | C7H8N2O | 613-92-3 | Details |
| Benzene, 1,1'-(1,2-ethynediyl)bis[3,5-dibromo- | C14H6Br4 | 448895-60-1 | Details |
| Levilimab | 2035008-70-7 | Details |
| 4-(pyridin-4-ylmethyl)pyridine | C11H10N2 | 60776-05-8 | Details |
| 2,5-Cyclohexadiene-1,4-dione, 2,5-bis[(2-methylphenyl)amino]- | C20H18N2O2 | 252950-56-4 | Details |
| 2,5-Cyclohexadiene-1,4-dione, 2-[(1-methylethyl)amino]-5-(phenylamino)- | C15H16N2O2 | 68054-73-9 | Details |
| 2,5-di(pyridin-2-yl)-1H-pyrrole | C14H11N3 | 60779-56-1 | Details |
| Benzoic acid, 4-[[6-[(1-oxo-2-propen-1-yl)oxy]hexyl]oxy]-, 4-[[6-[(1-oxo-2-propen-1-yl)oxy]hexyl]oxy]phenyl ester | C31H38O8 | 151464-39-0 | Details |
| Ethanamine, 2-[[2-(ethylthio)ethyl]thio]-N-[2-[[2-(ethylthio)ethyl]thio]ethyl]- | C12H27NS4 | 219658-99-8 | Details |
| 2,3,4,5,6-pentaiodobenzoic acid | C7HI5O2 | 64385-02-0 | Details |
| 4',4,4''-TRIMETHYL-2,2':6',2''-TERPYRIDINE | C18H17N3 | 33354-75-5 | Details |
| Research Grade Quetmolimab | 2084037-83-0 | Details |
| 1H-Pyrazolo[3,4-d]pyrimidine-4,6-diamine, 3-iodo | C5H5IN6 | 398117-44-7 | Details |
| Semorinemab | 2159141-27-0 | Details |
| N3,N3,N6,N6-tetraphenyl-9H-carbazole-3,6-diamine | C36H27N3 | 608527-58-8 | Details |
| Tris(4-bromophenyl)phosphane | C18H12Br3P | 29949-81-3 | Details |
| Tidutamab | 2148354-90-7 | Details |
| Atoltivimab | 2135632-29-8 | Details |
| Fianlimab | 2126132-98-5 | Details |
| Benzene, 1-[(1E)-2-phenylethenyl]-4-(2-phenylethynyl)- | C22H16 | 173035-17-1 | Details |
| 9,10-Di(pyridin-4-yl)anthracene | C24H16N2 | 194861-72-8 | Details |
| 4-Chloro-6-methoxymethyl-2-phenylpyrimidine | C12H11ClN2O | 325685-59-4 | Details |
| 1,3,6,8-Tetraphenylpyrene | C40H26 | 13638-82-9 | Details |
| Pyridine, 4,4'-(2,5-dibromo-1,4-phenylene)bis | C16H10Br2N2 | 2020402-43-9 | Details |
| 5,5'-Bi-1H-benzotriazole (8CI,9CI) | C12H8N6 | 15805-13-7 | Details |
| Avdoralimab | 2226393-85-5 | Details |
| Envafolimab | 2102192-68-5 | Details |
| Garadacimab | 2162134-62-3 | Details |
| Elipovimab | 2101210-43-7 | Details |
| Cobolimab | 2022215-65-0 | Details |
| 4-(4-pyridin-4-ylbutyl)pyridine | C14H16N2 | 2029-58-5 | Details |
| Tri(pyridin-4-yl)amine | C15H12N4 | 153467-50-6 | Details |
| 4-chloro-2,6-dimethylquinazoline | C10H9ClN2 | 1429782-21-7 | Details |
| 5''-Bromo-2,2':5',2''-terthiophene-5-carboxaldehyde | C13H7BrOS3 | 161726-69-8 | Details |
| HS-10352 Impurity D | C7H14N2O3 | 2276229-34-4 | Details |
| Pyridinium, 4-(9-anthracenyl)-2-fluoro-1-methyl-, iodide (1:1) | C20H15FIN | 2376179-18-7 | Details |
| 3,3'-Bi-1,2,4-oxadiazole]-5,5'-dimethanol | C6H6N4O4 | 2241022-97-7 | Details |
| 6,6''-dimethyl-2,2':6',2''-terpyridine | C17H15N3 | 33777-92-3 | Details |
| Acetylcysteine Impurity 68 | C6H11NO2 | 74562-18-8 | Details |
| Ieramilimab | 2137049-37-5 | Details |
| Cendakimab | 2151032-62-9 | Details |
| Etokimab | 2022981-44-6 | Details |
| 1,4-dimethyl-1,4-diazabicyclo[2.2.2]octane-1,4-diium bromide | C8H18BrN2+ | 5450-74-8 | Details |
| 2-methoxy-N,N-bis(2-methoxyethyl)ethanamine | C9H21NO3 | 3235-51-6 | Details |
| 6,6'-dinitro-diphenic acid diethyl ester | C18H16N2O8 | 200116-21-8 | Details |
| 1,4-Benzenedicarboxylic acid, 2,5-bis[[[[4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenyl]methoxy]carbonyl]amino]-, 1,4-diethyl ester | C40H50B2N2O12 | 1609956-75-3 | Details |
| Pyridinium, 4-carboxy-1-[(4-carboxyphenyl)methyl]-, bromide (1:1) | C14H12BrNO4 | 1451254-94-6 | Details |
| 4,4'-bithiazole]-2,2'-diamine dihydrobromide | C6H7BrN4S2 | 854455-31-5 | Details |
| 1,2,4,5-TETRAIODOBENZENE | C6H2I4 | 636-31-7 | Details |
| 2,5-Cyclohexadiene-1,4-dione, 2-(cyclohexylamino)-5-(phenylamino)- | C18H20N2O2 | 68054-78-4 | Details |
| 1-Boc-2-(cyanoMethyl)pyrrolidine | C11H18N2O2 | 1092352-11-8 | Details |
| Benzoic acid, 4-bromo-2,3,5,6-tetramethyl-, methyl ester | C12H15BrO2 | 28195-39-3 | Details |
| Tetrabromo-thieno[3,2-b]thiophene | C6Br4S2 | 124638-53-5 | Details |
| Pozelimab | 2096328-94-6 | Details |
| Tamrintamab | 2148325-59-9 | Details |
| Bedinvetmab | 2171034-69-6 | Details |
| Cinpanemab | 2094516-02-4 | Details |
| 1,3,5-Benzenetricarboxylic acid, 1,3,5-tri-3-pyridinyl ester | C24H15N3O6 | 1092649-22-3 | Details |
| N,N'-bis(2-methylphenyl)benzene-1,4-diamine | C20H20N2 | 15017-02-4 | Details |
| 1H-1,2,4-Triazole,1-acetyl-(6CI,7CI,8CI,9CI) | C4H5N3O | 15625-88-4 | Details |
| 4'-hydroxy-[1,1'-biphenyl]-3-carbaldehyde | C13H10O2 | 28314-95-5 | Details |
| Product Total： Product Page： | ||||
| 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 | ||||